FIELD: chemistry.
SUBSTANCE: invention is related to a new compound or a pharmaceutically acceptable salt thereof, as well as to a pharmaceutical composition containing them. The subject compound, or a pharmaceutically acceptable salt thereof, has autophagy-activating effects and thus can be used to prevent or treat diseases associated with autophagy regulation.
EFFECT: development of new compounds having excellent effects for activating autophagy.
4 cl, 5 dwg, 1 tbl, 96 ex.
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| AZABICYCLOCOMPOUND AND ITS SALT | 2010 |
|
RU2565078C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| INDANONE DERIVATIVE, ITS PHARMACEUTICALLY ACCEPTABLE SALT OR ENANTIOMER, METHOD FOR PRODUCING IT AND PHARMACEUTICAL COMPOSITION CONTAINING IT AND APPLICABLE FOR PREVENTING OR TREATING VIRAL DISEASE | 2012 |
|
RU2574591C2 |
| NOVEL DERIVATIVE OF PURINYLPYRIDINYLAMINO-2,4-DIFLUOROPHENYLSULPHONAMIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH HAS INHIBITION ACTIVITY WITH RESPECT TO RAF-KINASE, CONTAINING CLAIMED COMPOUND AS ACTIVE INGREDIENT | 2011 |
|
RU2550038C2 |
| NOVEL 2-ARYLTHIAZOLE DERIVATIVE OR SALT THEREOF, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2021 |
|
RU2822057C1 |
| 5-SUBSTITUTED INDAZOLE AS KINASE INHIBITORS | 2008 |
|
RU2487873C2 |
| TREATMENT METHOD | 2012 |
|
RU2621148C2 |
| NOVEL AROMATISING SUBSTANCES, TASTE MODIFIERS, FLAVOURING COMPOUNDS, TASTE BOOSTERS, UMAMI OR SWEET TASTE ENDOWING COMPOUNDS, AND/OR BOOSTERS AND USE THEREOF | 2004 |
|
RU2419602C2 |
